FIELD: medicine.
SUBSTANCE: one should apply hydrosulfate carbon-mercury complex (HCMC) containing below 50 mcg mercury in 0.05 ml preparation and, also, selenic phospholipoglycoprotein substance (SPLGPS) and/or selenic carotinoprotein substance (SCPS) of immunocorrecting and immunomodulating actions. Moreover, during 3 mo HCMC should be introduced perorally at the dosage of 0.05 ml preparation for 1-2 d, and selenic-protein substances should be introduced parenterally at daily dosage of 0.2-0.4 ml/2-10 ml physiological solution. The method provides complex impact onto body immune system by restoring and activating immunoreceptors and, also, onto retroviruses by causing their destruction or suppression of their activity.
EFFECT: higher efficiency of therapy.
8 cl, 9 dwg, 2 ex, 4 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF TREATING CHRONIC DISEASES OF EAR-NOSE-THROAT ORGANS WITH VIRAL, BACTERIAL, AND MIXED VIRAL-BACTERIAL ETIOLOGY IN HIV-INFECTED CHILDREN AND ADOLESCENTS | 2004 | 
 | RU2305558C2 | 
| NANOMOLECULAR SELENIUM-TERPENE-PROTEIN AGENT AND METHOD FOR TREATMENT OF PATIENTS WITH DEPENDENCE FROM PSYCHOACTIVE SUBSTANCES | 2003 | 
 | RU2242235C1 | 
| CHELATED MERCURY COMPLEXES WITH CYSTEINE AND METHIONINE, METHOD FOR PREPARING THEM, AND DRUG PREPARATION MERCURID APOPTOSIS MODULATOR SHOWING ANTICANCER, ANTIVIRAL, ANTIPARASITIC AND IMMUNOMODULATING ACTION | 2010 | 
 | RU2456001C2 | 
| METHOD OF DIAGNOSING EARLY MANIFEST CONGENITAL SYPHILIS | 2009 | 
 | RU2402775C1 | 
| AGENT CARBON-MERCURY HYDROSULFATE COMPLEX AND METHOD OF TREATMENT OF INFECTIOUS INFLAMMATORY SICKNESSES | 2002 | 
 | RU2196590C1 | 
| HIV-POSITIVE PATIENTS TREATMENT MODE | 2007 | 
 | RU2360694C1 | 
| DIAGNOSTIC TECHNIQUE FOR HEPATIC CIRRHOSIS (STAGE F4) IN THE OUTCOME OF CHRONIC VIRAL HEPATITIS C | 2019 | 
 | RU2724595C1 | 
| METHOD OF PREDICTING COMPLICATIONS AFTER COVID-19 IN PERSONS WITH COMORBID BACKGROUND IN THE ARCTIC REGION | 2023 | 
 | RU2812780C1 | 
| IMMUNOCORRECTING AGENT AND METHOD OF IMMUNOCORRECTION | 1999 | 
 | RU2138271C1 | 
| METHOD OF PREDICTING PROGRESSION OF HIV INFECTION IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY | 2019 | 
 | RU2697392C1 | 
Authors
Dates
2004-10-10—Published
2003-07-02—Filed